0001628280-24-049897.txt : 20241204 0001628280-24-049897.hdr.sgml : 20241204 20241204153553 ACCESSION NUMBER: 0001628280-24-049897 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241202 FILED AS OF DATE: 20241204 DATE AS OF CHANGE: 20241204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: de Verneuil Vanina CENTRAL INDEX KEY: 0002036234 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39083 FILM NUMBER: 241526042 MAIL ADDRESS: STREET 1: C/O VIR BIOTECHNOLOGY, INC. STREET 2: 1800 OWENS STREET, SUITE 900 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vir Biotechnology, Inc. CENTRAL INDEX KEY: 0001706431 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 812730369 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1800 OWENS STREET STREET 2: SUITE 900 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-906-4324 MAIL ADDRESS: STREET 1: 1800 OWENS STREET STREET 2: SUITE 900 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 wk-form4_1733344540.xml FORM 4 X0508 4 2024-12-02 0 0001706431 Vir Biotechnology, Inc. VIR 0002036234 de Verneuil Vanina C/O VIR BIOTECHNOLOGY, INC. 1800 OWENS STREET, SUITE 900 SAN FRANCISCO CA 94158 0 1 0 0 EVP and General Counsel 0 Common Stock 2024-12-02 4 S 0 76 8.2201 D 56973 D The shares were sold pursuant to a sale instruction entered into on May 28, 2024, whereby shares purchased on November 29, 2024 pursuant to the Issuer's employee stock purchase program were automatically sold six months after the instruction date. Reflects ownership after acquisition by the reporting person on November 29, 2024 of 76 shares of common stock pursuant to the Issuer's employee stock purchase program, and sale of such shares on December 2, 2024. /s/ Vanina de Verneuil 2024-12-04